TNF and Sepsis: Many anti-inflammatory drugs that inhibit cytokines have been developed to retard the inflammation caused by pathogenic bacteria; however, the treatment of TNF-α neutralizing antibodies, soluble TNF receptors, and IL-1 receptor antagonists had no therapeutic effect on patients with sepsis in clinical trials (Clark et al., 1998; Dinarello, 2000).